.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020864

« Back to Dashboard
NDA 020864 describes MAXALT, which is a drug marketed by Merck and is included in two NDAs. It is available from five suppliers. Additional details are available on the MAXALT profile page.

The generic ingredient in MAXALT is rizatriptan benzoate. There are twenty-two drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the rizatriptan benzoate profile page.

Summary for NDA: 020864

Tradename:
MAXALT
Applicant:
Merck
Ingredient:
rizatriptan benzoate
Patents:0
Therapeutic Class:Antimigraine Agents

Pharmacology for NDA: 020864

Suppliers and Packaging for NDA: 020864

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MAXALT
rizatriptan benzoate
TABLET;ORAL 020864 NDA Merck Sharp & Dohme Corp. 0006-0266 0006-0266-18 18 POUCH in 1 CARTON (0006-0266-18) > 1 TABLET in 1 POUCH (0006-0266-01)
MAXALT
rizatriptan benzoate
TABLET;ORAL 020864 NDA Merck Sharp & Dohme Corp. 0006-0267 0006-0267-18 18 POUCH in 1 CARTON (0006-0267-18) > 1 TABLET in 1 POUCH (0006-0267-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 5MG BASE
Approval Date:Jun 29, 1998TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 10MG BASE
Approval Date:Jun 29, 1998TE:ABRLD:Yes

Expired Orange Book Patents for NDA: 020864

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck
MAXALT
rizatriptan benzoate
TABLET;ORAL020864-001Jun 29, 19985,298,520*PED► subscribe
Merck
MAXALT
rizatriptan benzoate
TABLET;ORAL020864-002Jun 29, 19985,602,162*PED► subscribe
Merck
MAXALT
rizatriptan benzoate
TABLET;ORAL020864-002Jun 29, 19985,298,520*PED► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc